Impaired Efferocytosis in Human Chronic Granulomatous Disease Is Reversed by Pioglitazone Treatment
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2015.07.034
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2015
Authors
Publisher
Elsevier BV